Literature DB >> 17299724

Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy.

Simona Fiore, Enrico Ferrazzi, Marie-Louise Newell, Daria Trabattoni, Mario Clerici.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17299724     DOI： 10.1086/511983

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Antiretrovirals in pregnancy: a note of caution.

Authors:  D Heather Watts; Lynne M Mofenson
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

2.  Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.

Authors:  R Kreitchmann; S X Li; V H Melo; D Fernandes Coelho; D H Watts; E Joao; C M Coutinho; J O Alarcon; G K Siberry
Journal:  BJOG       Date:  2014-03-07       Impact factor: 6.531

3.  PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.

Authors:  Maganizo B Chagomerana; William C Miller; Brian W Pence; Mina C Hosseinipour; Irving F Hoffman; Robert J Flick; Hannock Tweya; Soyapi Mumba; Frank Chimbwandira; Kimberly A Powers
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

4.  Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

Authors:  Rebecca Zash; Denise L Jacobson; Modiegi Diseko; Gloria Mayondi; Mompati Mmalane; Max Essex; Chipo Petlo; Shahin Lockman; Joseph Makhema; Roger L Shapiro
Journal:  JAMA Pediatr       Date:  2017-10-02       Impact factor: 16.193

5.  Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region.

Authors:  Marie C D Stoner; Bellington Vwalika; Marcela Smid; Andrew Kumwenda; Elizabeth Stringer; Benjamin H Chi; Jeff S A Stringer
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

6.  Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana.

Authors:  Rebecca Zash; Sajini Souda; Jennifer Y Chen; Kelebogile Binda; Scott Dryden-Peterson; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

7.  Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).

Authors:  Sufia Dadabhai; Luis Gadama; Rachel Chamanga; Rachel Kawalazira; Chaplain Katumbi; Bonus Makanani; Dingase Dula; Nan Hua; Bryan Lau; Macpherson Mallewa; Taha E Taha
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

8.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

9.  Combination antiretroviral use and preterm birth.

Authors:  D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

Review 10.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.